Skip to content

The role of pre- and probiotics in infections in term infants (De role van pre- en probiotica in infecties in a terme geboren kinderen)

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN65140085
Enrollment
375
Registered
2008-09-12
Start date
2007-04-01
Completion date
Unknown
Last updated
2015-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Heathy term infants with intercurrent diseases: diarrhoea and respiratory infections Neonatal Diseases Other conditions originating in the perinatal period

Interventions

Treatment consists of three types of infant formula: 1. Standard infant formula (frisolac 1) without addition of prebiotics or probiotics 2. Standard infant formula with addition of galacto-oligos
0.8 g/100 ml (Vivinal Domo, The Netherlands. GOS 10 contains: galacto-oligosaccarides 28.5%, lactose 36%, glucose 9.5%, galactose 0.5%, proteins 17.5%, minerals 3.5%, fat 1.5%, moisture 3.0%) 3. Stan

Sponsors

Royal Friesland Foods B.V. (The Netherlands)
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Healthy term infants with a post-menstrual age of 37 - 42 weeks, either sex 2. Birth weight between P10 and P90 3. Informed consent of both parents

Exclusion criteria

Exclusion criteria: 1. Neonatal sepsis 2. Severe congenital malformations 3. Birth asphyxia (apgar less than six at 5 minutes, and/or umbilical cord pH less than 7.00 and/or necessity of reanimation) 4. Admission to a paediatric ward 5. No Dutch or English speaking parents 6. Antibiotics to the mother during labour 7. Antibiotics to the infant in the first week of life 8. History of allergy with parents or siblings

Design outcomes

Primary

MeasureTime frame
1. Frequency, incidence and duration of diarrhoea and respiratory infections, measured during the first 6 months of life and evaluated by the questionnaires 2. Composition of gut flora, evaluated at week 6, 3 months and 6 months of life (during the period infants receive the study feeds)

Secondary

MeasureTime frame
1. Growth (head circumference, length and weight), measured in the out-patient clinic at 3 and 6 months 2. Feeding tolerance (pattern of defaecation, consistence of faeces, crying, vomiting, stomach ache), assessed with standardised questions

Countries

Netherlands

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026